Back to Results
First PageMeta Content
Immunology / Monoclonal antibodies / Arthritis / Autoimmune diseases / TNF inhibitor / Adalimumab / Etanercept / Golimumab / Infliximab / Medicine / Pharmacology / Immunosuppressants


DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS August 2009 I.
Add to Reading List

Document Date: 2009-10-21 16:35:34

Open Document

File Size: 2,89 MB

Share Result on Facebook

Facility

TRICAREMail Order Pharmacy / Fort Sam Houston / Pharmacy Outcomes Research Team / DoD Pharmacoeconomic Center / /

MedicalCondition

tumor necrosis factor alpha / severely active psoriatic arthritis / severely active rheumatoid arthritis / active ankylosing spondylitis / /

MedicalTreatment

CPR / /

Organization

DoD Pharmacoeconomic Center / P&T Committee / FDA / DoD P&T Committee / Department of Defense / DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS / /

Person

A. Targeted Immunomodulatory Biologics / /

Position

Acting Director / TMA / Acting Director / Director / TMA / Page 30f49 Acting Director / /

Product

Humira / Orencia / Kineret / Remicade / Golimumab injection / Rituxan / Enbrel / /

ProvinceOrState

Texas / /

Technology

alpha / /

SocialTag